Press Release Archives - Page 2 of 3 - American Brain Tumor Association

ABTA Announces $1.3 Million in New Funding to Accelerate Adult and Pediatric Brain Tumor Research

The American Brain Tumor Association (ABTA) today announced the funding of $1.37 million towards 23 new research grants to advance brain tumor science and treatments, across all brain tumor types and ages. Dedicated to advancing the field of neuro-oncology and accelerating the discovery of life-saving treatments, the ABTA is proud to have invested more than $35 million, to approximately 700 researchers to support 800 projects, to date.

ABTA Announces $50-Million Fundraising Campaign to Accelerate Research, Improve Lives of Brain Tumor Patients

A champion of the brain tumor community for 50 years running, the American Brain Tumor Association (ABTA) has launched its most ambitious undertaking yet – a five-year, $50-million fundraising campaign called Meet Hope Head On.

The Meet Hope Head On campaign will focus on three pillars: tripling the ABTA’s research investment, doubling the number of patients served, and doubling federal funding for brain tumor research. Throughout its 50-year history, the ABTA has provided vital seed money to fund high-risk, high-reward research grants which have contributed to significant breakthroughs in treating brain tumors by many of the country’s leading researchers.

American Brain Tumor Association Awards 20 Research Grants to Advance Brain Tumor Science and Discoveries

The American Brain Tumor Association (ABTA) today announced the funding of $821,000 towards 20 new research grants to advance brain tumor science and treatments. With more than $34 million invested in research to date, across all brain tumor types and ages, the ABTA research program plays a critical role in advancing the understanding of brain tumors and building the next generation of brain tumor researchers.

ABTA SURVEY FINDS DISPARITIES IN CARE OF PATIENTS WITH METASTATIC BRAIN TUMORS

A first-of-its-kind, cross-sectional survey of patients, caregivers and physicians on the diagnosis and treatment of brain metastases, conducted by the American Brain Tumor Association (ABTA), as part of its Metastatic Brain Tumor Initiative, revealed disparities in practice patterns and communication around metastatic brain tumors. These data highlight the need to increase accessibility to clinical trials, establish clear standards of care and improve physician-patient communication reflective of the unique needs of patients with brain metastases (BM). The survey results have been published open access in the journal Neuro-Oncology Practice.

ABTA Awards 11 Research Grants to Advance Brain Tumor Research

The American Brain Tumor Association (ABTA) persists in its mission, announcing today the investment of $368,000 towards 11 new research grants to foster innovation in diagnosis and treatment of brain tumors in adults and children.

A Statement of Unity

American Brain Tumor Association (ABTA) today announced a new partnership with the Southeastern Brain Tumor Foundation (SBTF) to accelerate brain tumor research. Through this partnership, the Southeastern Brain Tumor Foundation will invest $50,000 in the ABTA research program to fund one glioblastoma immunotherapy research project.

American Brain Tumor Association and Southeastern Brain Tumor Foundation Announce Partnership to Accelerate Brain Tumor Research

American Brain Tumor Association and Uncle Kory Foundation Announce Partnership to Accelerate Brain Tumor Research

American Brain Tumor Association announces a new partnership with the Uncle Kory Foundation to accelerate brain tumor research. Through this partnership, the Uncle Kory Foundation will invest $100,000 in the ABTA research program to fund two glioblastoma research projects.

American Brain Tumor Association Invests $1.1 Million Across 18 Research Projects to Accelerate Brain Tumor Research for Adults and Children

As the nation’s first nonprofit organization committed to funding brain tumor research and providing education and information on all tumor types, the American Brain Tumor Association (ABTA) today announced its